Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/29/2012CN102648939A Preparation method for geum aleppicum polyphenol
08/29/2012CN102648925A Preparation method of achyranthes bidentata saponin
08/29/2012CN102648924A Anti-tumor and immunity-enhancing activity of Fomitopsis pinicola Karst fermentation product
08/29/2012CN102648921A Medicinal combination for treating non-small cell lung cancer
08/29/2012CN102648917A Application of vitamin D3 in preparing medicine for treating multiple myeloma
08/29/2012CN102648912A New use of 4-amino piperidines compound
08/29/2012CN102648911A Sensitizer, pharmaceutical composition, kit and use for target therapy
08/29/2012CN102648910A Immune enhancement composition and kit and use thereof
08/29/2012CN102648909A Sensitizer, kit and use for cancer therapy
08/29/2012CN102648903A Preparation method for beta-cyclodextrin inclusion compound of beta-carotene
08/29/2012CN102293778B Application of isoflavone compound to preparation of antitumor medicines or food
08/29/2012CN102250189B Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses
08/29/2012CN102145159B Ginger and elecampane composition, preparation method of ginger and elecampane composition and use of ginger and elecampane composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy
08/29/2012CN102078351B Composition for treating cancer
08/29/2012CN102058579B Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis
08/29/2012CN102038935B Application of Cucurmosin in preparation of medicaments for treating cervical cancer
08/29/2012CN102038934B Application of cucurmosin in preparation of drug for treating breast cancer
08/29/2012CN102030765B Ether-linked porphyrin dimer salt and preparation method thereof
08/29/2012CN102028722B Extract of effective parts of total saponins in pterocephalus hookeri as well as preparation method and application thereof
08/29/2012CN102008432B Sodium demethylcantharidate medicinal composition for injection and preparation method thereof
08/29/2012CN102000215B Method for preparing total lignans of Indian stringbush root
08/29/2012CN101979549B Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer
08/29/2012CN101979493B Anti-tumor kiwi liquor
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/29/2012CN101959501B Stabilized single-liquid pharmaceutical composition containing docetaxel
08/29/2012CN101928345B Human source antibody and humanization remolding method thereof
08/29/2012CN101912362B Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof
08/29/2012CN101909619B Composition comprising sesamin component and quercetin glycoside
08/29/2012CN101906102B Beta-carboline alkaloid derivative, preparation method and application thereof
08/29/2012CN101863925B Aryl ruthenium (11) composition and preparation method and application thereof
08/29/2012CN101812103B 6-methy salicylic acid synthetase transformed by genetic engineering and combinatorial biosynthesis of spirocyclic acetoacetic acid lactone antiboitic
08/29/2012CN101784544B Thiadiazinone derivatives
08/29/2012CN101717413B Chiral ruthenium coordination compound and application of same as anti-tumour medicine
08/29/2012CN101559076B Anti-tumor-stroma metalloprotease inhibitor
08/29/2012CN101538247B Preparation method of alkaloid compound
08/29/2012CN101538239B Antitumor antibiotic and preparation method thereof
08/29/2012CN101516882B Selective antagonists of A2A adenosine receptors
08/29/2012CN101491663B Traditional Chinese medicine composition for treating various cancer
08/29/2012CN101474388B Improved prescription of Xianchan tablet medicament and preparation method thereof
08/29/2012CN101454305B Flavonoid dimers and methods of making and using such
08/29/2012CN101331229B Immunostimulatory oligoribonucleotides
08/29/2012CN101272767B Morphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide
08/29/2012CN101269113B Quality control method for medicament composition for treating knubble
08/29/2012CN101163684B Quinazoline derivative having tyrosine kinase inhibitory activity
08/29/2012CN101155786B N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
08/28/2012WO2013130049A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents
08/28/2012US8252948 Fat composition
08/28/2012US8252916 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252804 Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
08/28/2012US8252800 Protein tyrosine kinase inhibitors
08/28/2012US8252780 Organometallic complexes as therapeutic agents
08/28/2012US8252765 Treatment of cancer by inhibition of IGFBPs and clusterin
08/28/2012US8252739 Albumin fusion proteins
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012US8252307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
08/28/2012US8252276 Cyclodextrin-based polymers for therapeutics delivery
08/28/2012US8252046 Drug-delivery endovascular stent and method for treating restenosis
08/28/2012CA2825216A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents
08/28/2012CA2711101C Fused heterocyclic derivatives and methods of use as c-met inhibitors
08/28/2012CA2703125C Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
08/28/2012CA2656910C Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
08/28/2012CA2581666C Process for producing concentrate of unsaturated fatty acid
08/28/2012CA2520515C S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/28/2012CA2455710C Calcium salts with cytotoxic activity
08/28/2012CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112956A2 Compounds and methods for targeting leukemic stem cells
08/23/2012WO2012112869A2 Targeted cancer therapy using ets transcriptional inhibitors
08/23/2012WO2012112847A1 mTOR/JAK INHIBITOR COMBINATION THERAPY
08/23/2012WO2012112841A2 [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
08/23/2012WO2012112798A1 Methods to enhance cell-mediated immunity
08/23/2012WO2012112708A1 Cytotoxic benzodiazepine derivatives and methods of preparation
08/23/2012WO2012112687A1 Methods of preparation of conjugates
08/23/2012WO2012112626A2 Compositions, devices and methods of use thereof for the treatment of cancers
08/23/2012WO2012112567A1 Small molecule inhibitors of agbl2
08/23/2012WO2012112547A1 Core-excited nanoparticles and methods of their use in the diagnosis and treatment of disease
08/23/2012WO2012112125A1 Use of magnetic vortex cores in magnetic resonance imaging and tumor treatment
08/23/2012WO2012112079A1 IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
08/23/2012WO2012111900A1 Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna
08/23/2012WO2012111790A1 Potentiator of antitumor activity of chemotherapeutic agent
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012111380A1 Auto-magnetic metal salen complex compound
08/23/2012WO2012111020A1 Pyrrolo [2,1-c]1,4]naphthodiazepine linked piperazine compounds and a process for the preparation thereof
08/23/2012WO2012111017A1 3-arylethynyl substituted quinazolinone compounds
08/23/2012WO2012111016A1 2-anilino nicotinyl linked 2-amino benzothiazole conjugates and process for the preparation thereof
08/23/2012WO2012110959A1 2-phenyl benzothiazole linked imidazole compounds as potential anticancer agents and process for the preparation thereof
08/23/2012WO2012110840A1 Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof
08/23/2012WO2012110774A1 Selective fak inhibitors
08/23/2012WO2012110773A1 Fak inhibitors
08/23/2012WO2012110768A1 Therapeutic uses of diarylalkanes such as mitotane
08/23/2012WO2012110636A2 Carrier peptides for cell delivery
08/23/2012WO2012110518A1 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
08/23/2012WO2012110425A1 Methods for monitoring the response to treatment and for treating colorectal cancer
08/23/2012WO2012110360A1 Antibody against the csf-1r
08/23/2012WO2012110092A1 Tamsulosin derivatives
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 2211